Yubo International Biotech Limited
YBGJ
$0.01
$0.005.26%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.56% | -162.62% | 75.80% | -50.36% | 50.12% |
| Total Depreciation and Amortization | 1.83% | -3.33% | 1.12% | 5.19% | -12.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.36% | -366.56% | 200.00% | 53.11% | -23.36% |
| Change in Net Operating Assets | 371.74% | -163.11% | 113.68% | 104.97% | -165.68% |
| Cash from Operations | 64.13% | -1,067.92% | 109.46% | 57.97% | -364.00% |
| Capital Expenditure | -- | -- | 200.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | 1,488.71% | -- | -100.00% |
| Total Debt Issued | -- | -100.00% | -29.41% | -73.10% | 331.58% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 202.36% |
| Cash from Financing | -- | -100.00% | -29.41% | -74.96% | 363.77% |
| Foreign Exchange rate Adjustments | -147.22% | 212.87% | -358.60% | 169.33% | -780.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -680.00% | -16.67% | -78.57% | 380.00% | 78.72% |